<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Hodges Pereira | Activity</title>
	<link>https://www.catswannabecats.com/members/stitchtower4/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/stitchtower4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hodges Pereira.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3d37d97ff23a9783df55f8a5b44a66ed</guid>
				<title>Hodges Pereira posted an update: Oral PARP inhibitors (PARPi) have dramatically changed the [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/22048/</link>
				<pubDate>Sat, 07 Jun 2025 07:43:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>Oral PARP inhibitors (PARPi) have dramatically changed the treatment landscape for patients with advanced ovarian cancer. However, a subset of patients discontinue PARPi due to treatment-related fatigue. The current study sought to explore patients&#8217; lived experiences with fatigue on PARPi.</p>
<p> We conducted individual semi-structured interviews&hellip;<span class="activity-read-more" id="activity-read-more-22048"><a href="https://www.catswannabecats.com/activity/p/22048/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cdfc8abf26179def0467e9ede0ba2313</guid>
				<title>Hodges Pereira posted an update: Children with self-limited focal epilepsies of childhood [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20748/</link>
				<pubDate>Fri, 06 Jun 2025 07:21:28 -0400</pubDate>

									<content:encoded><![CDATA[<p>Children with self-limited focal epilepsies of childhood (SLFE) are known to show impaired memory functions, particularly in the verbal domain. Interictal epileptiform discharges (IED) in these epilepsies are more pronounced in nonrapid eye movement (NREM) sleep. Nonrapid eye movement sleep is crucial for consolidation of newly-encoded memories.&hellip;<span class="activity-read-more" id="activity-read-more-20748"><a href="https://www.catswannabecats.com/activity/p/20748/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">aa274d9ebdb61797f5c91aace3c02dbe</guid>
				<title>Hodges Pereira posted an update: Furthermore, the protein expression levels of ATP synthase [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/8213/</link>
				<pubDate>Sat, 31 May 2025 20:51:07 -0400</pubDate>

									<content:encoded><![CDATA[<p>Furthermore, the protein expression levels of ATP synthase and mitochondrial fission factor were highest in the MP group, whereas citrate synthase, dynamin-related protein1, and fission1 remained unchanged in the three groups. The change trends of ATP synthase and citrate synthase activity were similar to that of protein expression among the three&hellip;<span class="activity-read-more" id="activity-read-more-8213"><a href="https://www.catswannabecats.com/activity/p/8213/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c0533524143ec3322a8fc576d53a9207</guid>
				<title>Hodges Pereira became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/8082/</link>
				<pubDate>Sat, 31 May 2025 20:39:22 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>